Molina and Fresneda developed a second approach to obtain the tricyclic variolin core without the ester group at C-7. After the
N-SEM-deprotection of
19, a nitroaldol condensation with nitromethane led to the formation of
25. Treatment with lithium aluminum hydride gave the corresponding 2-(2-aminoethyl)-7-azaindole, which was sequentially converted to the urea derivative
26 with benzyl isocyanide (
22) without isolation. The
26 was dehydrated to the carbodiimide, which subsequently cyclized to the dihydropyrimidine
27 using the Appel reagent (CCl
4/PPh
3/NEt
3). Applying both synthetic approaches, an oxygen substituent is placed at C-4 and a nitrogen substituent at C-9. The next step was to introduce the 2-aminopyrimidine ring at C-5, consequently leading both approaches to the acylated intermediate
31. The reaction of
23 with phosphorus oxychloride and
N,
N-dimethylacetamide (DMA) (
28) allowed the direct introduction of an acetyl group at C-5. Ester hydrolysis led to the carbonic acid
30, and the thermal treatment forced the formation of intermediate
31 by decarboxylation. The route starting from
27 began with the introduction of a bromine substituent at C-5 and the reaction of bromine
32 with
n-tributyltin(1-ethoxyvinyl)stannane (
33) in the presence of dichlorobis (triphenylphosphine)-palladium(II) introduced to the acetyl group at C-5. Oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) gave the intermediate
31 (
Figure 74).
Figure 74. Introduction of an acetyl group at C-5
[3]
The 2-aminopyrimidine substituent was synthesized using a protocol developed by Bredereck (
Figure 85)
[5]. Enaminone
36 was synthesized from
31 with
N,
N’-dimethylformamide di-
tert-butylacetal (
35) in DMF. Condensation with guanidine hydrochloride (
37) led to ring closure and formed the desired 2-aminopyrimidine
38.
Figure 85. Synthesis of the 2-aminopyrimidine ring to give access to variolin B (
1)
[3]
1.3. Variolin B Approach by Alvarez
In 2003, Alvarez published the synthesis of variolin B (
1) and the synthetic analog desoxyvariolin B
[6][7][8]. Starting from 4-methoxy-7-azaindole (
40), a lithium carboxylate was used as an
N-protecting group as well as an
ortho-directing substituent to form a 2-lithio-7-azaindole with a protocol by Katritzky
[9]. Reaction with 2-(1,3-dioxoisindolin-2-yl)acetaldehyde (
41) gave the alcohol
42 that was protected with dihydropyran.
N-deprotection of
43 by hydrazinolysis gave the aminoacetal
44. Ring closure was achieved by the reaction with
N-tosylcarbonimidic dichloride (
45) and diisopropylethylamine (DIPEA) giving
46 in a diasteriometric mixture in a ratio of 1:1. Removal of the
O-tetrahydropyran (THP) protecting group and elimination of the resulting hydroxy group by the formation of its mesylate and treatment with triethylamine afforded the pyridopyrrolopyrimidine scaffold (
48). Regioselective iodination with
N-iodosuccinimide (NIS) gave the key intermediate
49 (
Figure 96).
Figure 96. Synthesis of the key intermediate iodide
49
[6].
A Stille reaction of
49 and 2-acetylamino-4-trimethylstannylpyrimidine (
50) in the presence of tris(dibenzylideneacetone)dipalladium(0) afforded
51. The
O-demethylation and
N-acetyl-deprotection were achieved by the treatment of
51 with hydrobromic acid, and after reductive photolysis with hydrazine as a reducing agent and 1,4-dimethoxybenzene as an electron source, the tosyl group was cleaved to give variolin B (
1) in a 10-step synthesis with an overall yield of 1% (
Figure 107).
Figure 107. Synthesis of variolin B (
1) via Stille coupling as a key reaction step
[6].
1.4. Synthesis of Variolin B by Burgos and Vaquero
The 2008 approach by Burgos and Vaquero to synthesize variolin B (
1) followed the strategy to design the highly functionalized trihalo-substituted pyridopyrrolopyrimidine core
55 and introduce the substituents via palladium-mediated cross-coupling reactions
[10][11]. The functionalized 7-azaindole
53 was synthesized from 7-azaindole in six single steps
[12]. The
53 was reacted with
N-tosylmethyl dichloroformimide (
54) under phase-transfer conditions in the two-phase system LiOH (aq., 30%)/CH
2Cl
2 (1:1) with tetrabutylammonium chloride to give the trihalo-substituted compound
55. The C-9 amino substituent was introduced by a palladium-mediated C-N bond formation, using lithium bis(trimethylsilyl)amide (LiHMDS) and triphenylsilylamine as an ammonia source. The reaction required the use of the ligand [1,1′-biphenyl]-2-yldi-
tert-butylphosphane (JohnPhos). After
N-acetyl-protection,
56 was obtained (
Figure 118).
Figure 118. Synthesis of the trihalo core and introduction of the C-9 amino substituent
[10].
Next, in a debromination-iodination process, tris(trimethylsilyl)silane (TTMSS) and azobisisobutyronitrile (AIBN) and subsequently NIS were used to exchange the bromo compound
56 to the more reactive iodo derivative
57. In a palladium-catalyzed cross-coupling reaction with the pyrimidyl stannyl reagent
58, the C-C bond at C-5 was formed and the deprotection of both amino groups led to
59. Then, in a palladium-promoted C-O coupling microwave (MW) reaction with sodium
tert-butoxide, the
tert-butyl group was introduced at C-4 to give the
tert-butyl ether
60, and in a final step, the
tert-butyl moiety was cleaved to give variolin B (
1) (
Figure 129). Starting from
53, variolin B was synthesized in seven steps with an overall yield of 5%
[10][11].